Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/109998
DC Field | Value | Language |
---|---|---|
dc.contributor | Research Institute for Future Food | - |
dc.contributor | Department of Food Science and Nutrition | - |
dc.creator | Li, YH | - |
dc.creator | Jiang, ZX | - |
dc.creator | Xu, Q | - |
dc.creator | Jin, TT | - |
dc.creator | Huang, JF | - |
dc.creator | Luan, X | - |
dc.creator | Li, C | - |
dc.creator | Chen, XY | - |
dc.creator | Wong, KH | - |
dc.creator | Dong, XL | - |
dc.creator | Sun, XR | - |
dc.date.accessioned | 2024-11-20T07:30:47Z | - |
dc.date.available | 2024-11-20T07:30:47Z | - |
dc.identifier.issn | 0753-3322 | - |
dc.identifier.uri | http://hdl.handle.net/10397/109998 | - |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Masson | en_US |
dc.rights | © 2024 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). | en_US |
dc.rights | The following publication Li, Y.-H., Jiang, Z.-X., Xu, Q., Jin, T.-T., Huang, J.-F., Luan, X., Li, C., Chen, X.-Y., Wong, K.-H., Dong, X.-L., & Sun, X.-R. (2024). Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model. Biomedicine & Pharmacotherapy, 174, 116518 is available at https://doi.org/10.1016/j.biopha.2024.116518. | en_US |
dc.subject | Calcium-sensing receptor | en_US |
dc.subject | Gastrointestinal motility | en_US |
dc.subject | NPS-2143 | en_US |
dc.subject | Parkinson's disease | en_US |
dc.title | Inhibition of calcium-sensing receptor by its antagonist promotes gastrointestinal motility in a Parkinson’s disease mouse model | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.volume | 174 | - |
dc.identifier.doi | 10.1016/j.biopha.2024.116518 | - |
dcterms.abstract | Background: The Calcium-sensing receptor (CaSR) participates in the regulation of gastrointestinal (GI) motility under normal conditions and might be involved in the regulation of GI dysmotility in patients with Parkinson's disease (PD). | - |
dcterms.abstract | Methods: CaSR antagonist-NPS-2143 was applied in in vivo and ex vivo experiments to study the effect and underlying mechanisms of CaSR inhibition on GI dysmotility in the MPTP-induced PD mouse model. | - |
dcterms.abstract | Findings: Oral intake of NPS-2143 promoted GI motility in PD mice as shown by the increased gastric emptying rate and shortened whole gut transit time together with improved weight and water content in the feces of PD mice, and the lack of influence on normal mice. Meanwhile, the number of cholinergic neurons, the proportion of serotonergic neurons, as well as the levels of acetylcholine and serotonin increased, but the numbers of nitrergic and tyrosine hydroxylase immunoreactive neurons, and the levels of nitric oxide synthase and dopamine decreased in the myenteric plexus in the gastric antrum and colon of PD mice in response to NPS-2143 treatment. Furthermore, the numbers of c-fos positive neurons in the nucleus tractus solitarius (NTS) and cholinergic neurons in the dorsal motor nucleus of the vagus (DMV) increased in NPS-2143 treated PD mice, suggesting the involvement of both the enteric (ENS) and central (CNS) nervous systems. However, ex vivo results showed that NPS-2143 directly inhibited the contractility of antral and colonic strips in PD mice via a non-ENS mediated mechanism. Further studies revealed that NPS-2143 directly inhibited the voltage gated Ca2+ channels, which might, at least in part, explain its direct inhibitory effects on the GI muscle strips. | - |
dcterms.abstract | Interpretation: CaSR inhibition by its antagonist ameliorated GI dysmotility in PD mice via coordinated neuronal regulation by both ENS and CNS in vivo, although the direct effects of CaSR inhibition on GI muscle strips were suppressive. | - |
dcterms.abstract | Graphical abstract: [Figure not available: see fulltext.] | - |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | Biomedicine and pharmacotherapy, May 2024, v. 174, 116518 | - |
dcterms.isPartOf | Biomedicine and pharmacotherapy | - |
dcterms.issued | 2024-05 | - |
dc.identifier.scopus | 2-s2.0-85189507421 | - |
dc.identifier.eissn | 1950-6007 | - |
dc.identifier.artn | 116518 | - |
dc.description.validate | 202411 bcch | - |
dc.description.oa | Version of Record | en_US |
dc.identifier.FolderNumber | OA_Scopus/WOS | en_US |
dc.description.fundingSource | Others | en_US |
dc.description.fundingText | National Natural Science Foundation of China; Taishan Scholar Foundation of Shandong Province (CN); Shenzhen Fundamental Research Program | en_US |
dc.description.pubStatus | Published | en_US |
dc.description.oaCategory | CC | en_US |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0753332224004025-main.pdf | 9.78 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.